Another quarter down and our dedication to our mission remains unshaken, resulting in impressive Q2 growth and significant positive impacts on patient care. View the earnings report at: https://okt.to/r3vjSs #Earnings #FinancialResults
AtriCure, Inc.
Medical Equipment Manufacturing
Mason, Ohio 35,419 followers
We are passionately focused on healing the lives of those affected by Afib and pain after surgery.
About us
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
- Website
-
http://www.atricure.com
External link for AtriCure, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Mason, Ohio
- Type
- Public Company
- Founded
- 2000
- Specialties
- Medical Devices, Manufacturing, Atrial Fibrillation, and Maze IV Training
Locations
Employees at AtriCure, Inc.
Updates
-
Post-operative Afib (POAF) is the most common complication for patients undergoing a variety of cardiac surgeries. Options to prevent or treat this condition may include medications, overdrive atrial pacing or surgical ablation. To learn more about the latest POAF treatment strategies, visit: https://okt.to/BGfMe4 #Cardiology #Afib
-
Real-world data continues to demonstrate the efficacy of the hybrid convergent procedure in Advanced Afib patients. See the results of this innovative two-step approach first-hand by visiting: https://okt.to/ZNbKIh #HybridAFTherapy #Epeeps #CardiacSurgery
-
Are you a CRA with proven project management experience looking to join an innovative Medical Device company? The Clinical Project Manager will ensure successful completion of clinical trials by overseeing all aspects of program activities, budgeting and project planning. Take a look at what AtriCure has to offer. https://okt.to/1ujqLM
-
The burden of Afib often results in further health problems such as stroke and heart failure. Dr. Denis Bouchard explains the trends he’s seeing in his Afib patients. Visit actagainstafib.com to learn more about Afib treatment options and what conditions can develop from a diagnosis. #Afib
-
With dual-wall vacuum insulation to shield the shaft from reaching therapeutic temperatures, the cryoSPHERE®+ probe provides heightened safeguarding for surrounding tissue. Discover cryoSPHERE+, a non-opioid solution: https://okt.to/hglX6v #cryoNB
-
Today, we celebrate #NationalInternDay by recognizing the outstanding contributions of our interns and co-ops – a program total of more than 500 students representing 14 different departments! With fresh insights and unique viewpoints, AtriCure interns and co-ops create a lasting impact and play a crucial role in our success. Thank you for all you do! Looking for an internship or co-op this fall? Check out our openings at: https://okt.to/4GMnuZ #ThisisAtriCure
-
AtriClip® devices have unmatched experience backed by over 15 years of clinical data that demonstrate safe and effective use. Today, it’s the most widely implanted left atrial appendage management device worldwide. Discover why: https://okt.to/Sszr9t #AtriClip #LAAE
-
For some symptomatic IST patients, medicine hasn’t proven successful. Left with limited treatment options, the HEAL-IST Trial is set out to determine the safety and effectiveness of a hybrid procedure. Do you have patients with IST who may be eligible? Visit heal-ist.com to see the qualifications. #IST #Inappropriatesinustachycardia #ClincialTrial
-
Why are innovative ergonomics important? Every heart is unique, which makes every approach to surgical ablation different. The cryoICE® probes are retractable, malleable and have an ergonomic handle. Together, these advantages enable a wide range of placement options for cardiac surgeons. Learn more: https://okt.to/Gu6oUi